C70741|Anti-CD20_Monoclonal_Antibody_R7159|Modify|15-OCT-07|(null)|Anti-CD20_Monoclonal_Antibody_R159
C61411|Cancer_Disease_Progression|retire|29-OCT-07|(null)|(null)
C68555|Recommended_Intake_Property|retire|29-OCT-07|(null)|(null)
C70582|Vibration_Respone_Imaging|create|29-OCT-07|(null)|(null)
C70584|MITF_Gene|create|29-OCT-07|(null)|(null)
C70585|MITF_wt_Allele|create|29-OCT-07|(null)|(null)
C70586|Microphthalmia-Associated_Transcription_Factor|create|29-OCT-07|(null)|(null)
C70587|Hydrated_Sodium_Calcium_Aluminosilicate|create|29-OCT-07|(null)|(null)
C70588|Recurrent_Adult_Diffuse_Small_Cleaved_Cell_Lymphoma|create|29-OCT-07|(null)|(null)
C70589|Abundance|create|29-OCT-07|(null)|(null)
C70590|Subtraction|create|29-OCT-07|(null)|(null)
C70591|Gel_Warping_Algorithm|create|29-OCT-07|(null)|(null)
C70592|Well|create|29-OCT-07|(null)|(null)
C70594|Fluorine_18_Ethylcholine|create|29-OCT-07|(null)|(null)
C70595|Edit|create|29-OCT-07|(null)|(null)
C70596|Initial_Seed|create|29-OCT-07|(null)|(null)
C70597|Ceftobiprole_Medocaril|create|29-OCT-07|(null)|(null)
C70598|Broad-Spectrum_Human_Papillomavirus_Vaccine_V505|create|29-OCT-07|(null)|(null)
C70599|Negative_Selection|create|29-OCT-07|(null)|(null)
C70600|Tumor_Purging|create|29-OCT-07|(null)|(null)
C70601|Cellular_Therapy|create|29-OCT-07|(null)|(null)
C70602|Ph_Negative_BCR_Positive|create|29-OCT-07|(null)|(null)
C70603|Continued_Complete_Response|create|29-OCT-07|(null)|(null)
C70604|Primary_Refractory_Les_than_Partial_Response_PR_to_Initial_Therapy_Primary_Induction_Failure_Resistant_PIF_Res|create|29-OCT-07|(null)|(null)
C70605|Multiple_Myeloma-Light_Chain_Only|create|29-OCT-07|(null)|(null)
C70606|Multiple_Myeloma-IgA|create|29-OCT-07|(null)|(null)
C70607|Multiple_Myeloma-IgD|create|29-OCT-07|(null)|(null)
C70608|Multiple_Myeloma-IgE|create|29-OCT-07|(null)|(null)
C70609|Multiple_Myeloma-IgG|create|29-OCT-07|(null)|(null)
C70610|Multiple_Myeloma-IgM_not_Waldenstrom_Macroglobulinemia|create|29-OCT-07|(null)|(null)
C70611|Complement_Hemolytic_Activity_Assay|create|29-OCT-07|(null)|(null)
C70612|Tolerance_Induction_Pre_Solid_Organ_Transplant|create|29-OCT-07|(null)|(null)
C70613|Drug_Toxin-Induced_Aplastic_Anemia|create|29-OCT-07|(null)|(null)
C70614|HLA-DQB1_Gene|create|29-OCT-07|(null)|(null)
C70615|HLA-DQB1_wt_Allele|create|29-OCT-07|(null)|(null)
C70616|HLA_Class_II_Histocompatibility_Antigen_DQ1_Beta_Chain|create|29-OCT-07|(null)|(null)
C70617|Total_Complement_Assay|create|29-OCT-07|(null)|(null)
C70618|Complement_Component-4|create|29-OCT-07|(null)|(null)
C70619|Anticardiolipin_IgM_Antibody|create|29-OCT-07|(null)|(null)
C70620|Lupus_Anticoagulant_Antibody|create|29-OCT-07|(null)|(null)
C70621|CD34_Selection|create|29-OCT-07|(null)|(null)
C70622|Primary_Induction_Failure|create|29-OCT-07|(null)|(null)
C70623|Ph_Unknown_BCR_Positive|create|29-OCT-07|(null)|(null)
C70624|Ph_Positive_BCR_Unknown|create|29-OCT-07|(null)|(null)
C70625|Erastin_Analogue_PRLX93936|create|29-OCT-07|(null)|(null)
C70626|Transdermal_Patch_Dosing_Unit|create|29-OCT-07|(null)|(null)
C70627|Ph_Unknown_BCR_Negative|create|29-OCT-07|(null)|(null)
C70628|Ph_Unknown_BCR_Unknown|create|29-OCT-07|(null)|(null)
C70629|Ph_Negative_BCR-ABL_Negative|create|29-OCT-07|(null)|(null)
C70630|Ph_Negative_BCR_Unknown|create|29-OCT-07|(null)|(null)
C70631|TIFF|create|29-OCT-07|(null)|(null)
C70632|Alternative_Hematopoietic_Cell_Transplantation|create|29-OCT-07|(null)|(null)
C70633|Nodular_Partial_Remission|create|29-OCT-07|(null)|(null)
C70634|Destructive_Arthritis|create|29-OCT-07|(null)|(null)
C70635|Necrotizing_Vasculitis|create|29-OCT-07|(null)|(null)
C70636|Extra-Articular|create|29-OCT-07|(null)|(null)
C70637|Stringent_Complete_Response_sCR_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70638|Very_Good_Partial_Response_VGPR_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70639|Complete_Response_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70640|Plant-Derived_Hematopoiesis_Enhancer_PG2|create|29-OCT-07|(null)|(null)
C70641|Partial_Response_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70642|Stable_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70643|Progression_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70645|Relapse_from_Complete_Response_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70644|CEA-6D_VRP_Vaccine|create|29-OCT-07|(null)|(null)
C70646|CREST_Syndrome|create|29-OCT-07|(null)|(null)
C70647|Sicca_Syndrome|create|29-OCT-07|(null)|(null)
C70648|Lab_Lupus_Inhibitor|create|29-OCT-07|(null)|(null)
C70649|T_Cell_Chronic_Lymphocytic_Leukemia|create|29-OCT-07|(null)|(null)
C70650|Aminopeptidase_Inhibitor_CHR-2797|create|29-OCT-07|(null)|(null)
C70651|Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin|create|29-OCT-07|(null)|(null)
C70652|Manager|create|29-OCT-07|(null)|(null)
C70653|Inversion|create|29-OCT-07|(null)|(null)
C70654|Differential_In-Gel_Electrophoresis|create|29-OCT-07|(null)|(null)
C70655|Aurora_Kinase_Inhibitor_SNS-314|create|29-OCT-07|(null)|(null)
C70656|Point|create|29-OCT-07|(null)|(null)
C70657|International_Staging_System_for_Myeloma|create|29-OCT-07|(null)|(null)
C70658|ISS_Stage_I_Plasma_Cell_Myeloma|create|29-OCT-07|(null)|(null)
C70659|ISS_Stage_II_Plasma_Cell_Myeloma|create|29-OCT-07|(null)|(null)
C70660|ISS_Stage_III_Plasma_Cell_Myeloma|create|29-OCT-07|(null)|(null)
C70661|Microplate_Reader|create|29-OCT-07|(null)|(null)
C70662|Excitation|create|29-OCT-07|(null)|(null)
C70663|Unique_Identifier|create|29-OCT-07|(null)|(null)
C70664|Relevance|create|29-OCT-07|(null)|(null)
C70666|Mild|create|29-OCT-07|(null)|(null)
C70665|Human_Study_Subject|create|29-OCT-07|(null)|(null)
C70667|Severe|create|29-OCT-07|(null)|(null)
C70669|Automatic|create|29-OCT-07|(null)|(null)
C70670|Always|create|29-OCT-07|(null)|(null)
C70668|Human_Clinical_Study_Subject|create|29-OCT-07|(null)|(null)
C70671|Bead|create|29-OCT-07|(null)|(null)
C70672|Pore|create|29-OCT-07|(null)|(null)
C70673|Stationary_Phase|create|29-OCT-07|(null)|(null)
C70674|Recombinant_Human_EGF-rP64K_Montanide_ISA_51_Vaccine|create|29-OCT-07|(null)|(null)
C70675|Gadobutrol|create|29-OCT-07|(null)|(null)
C70676|Ex_vivo|create|29-OCT-07|(null)|(null)
C70677|Micronutrient-Fortified_Probiotic_Yogurt|create|29-OCT-07|(null)|(null)
C70678|Potential_Clinical_Study_Subject|create|29-OCT-07|(null)|(null)
C70679|Authorization_for_Release_of_Confidential_Health_Information|create|29-OCT-07|(null)|(null)
C70680|Healthcare_Payment_Method|create|29-OCT-07|(null)|(null)
C70681|Per_Diem_Payment_Method|create|29-OCT-07|(null)|(null)
C70682|Episode_of_Care_Payment_Method|create|29-OCT-07|(null)|(null)
C70683|Condition-Specific_Capitation_Payment_Method|create|29-OCT-07|(null)|(null)
C70684|Capitation_Payment_Method|create|29-OCT-07|(null)|(null)
C70685|HLA-A31_Positive_Cells|create|29-OCT-07|(null)|(null)
C70686|Healthcare_Payer|create|29-OCT-07|(null)|(null)
C70687|Waiver_of_Authorization_for_Release_of_Confidential_Health_Information|create|29-OCT-07|(null)|(null)
C70688|Primary_Healthcare_Payer|create|29-OCT-07|(null)|(null)
C70689|Quadrupole|create|29-OCT-07|(null)|(null)
C70690|Secondary_Healthcare_Payer|create|29-OCT-07|(null)|(null)
C70691|Third_Party_Healthcare_Payer|create|29-OCT-07|(null)|(null)
C70692|Workers_Compensation_Plan|create|29-OCT-07|(null)|(null)
C70693|Gradient|create|29-OCT-07|(null)|(null)
C70694|Managed_Healthcare_Plan|create|29-OCT-07|(null)|(null)
C70695|Social_Managed_Healthcare_Plan|create|29-OCT-07|(null)|(null)
C70696|Private_Health_Insurance|create|29-OCT-07|(null)|(null)
C70697|Reflectron|create|29-OCT-07|(null)|(null)
C70698|Time-of-Flight|create|29-OCT-07|(null)|(null)
C70699|Biospecimen|create|29-OCT-07|(null)|(null)
C70700|Method_of_Biospecimen_Collection|create|29-OCT-07|(null)|(null)
C70701|Fasting_Specimen|create|29-OCT-07|(null)|(null)
C70702|Non-Fasting_Specimen|create|29-OCT-07|(null)|(null)
C70703|Clinical_Study_Status|create|29-OCT-07|(null)|(null)
C70704|Planned_Clinical_Study|create|29-OCT-07|(null)|(null)
C70705|Component_of_Clinical_Study_Protocol|create|29-OCT-07|(null)|(null)
C70706|Clinical_Study_Targeted_Accrual|create|29-OCT-07|(null)|(null)
C70707|Planned_Duration_of_Study_Subject_Participation|create|29-OCT-07|(null)|(null)
C70708|Planned_Intervention_Duration_for_Study_Subject|create|29-OCT-07|(null)|(null)
C70709|Submission_Unit|create|29-OCT-07|(null)|(null)
C70710|Sequence_Number|create|29-OCT-07|(null)|(null)
C70711|Activity_Status|create|29-OCT-07|(null)|(null)
C70712|Status_of_Scheduled_Study_Activity_for_Study_Subject|create|29-OCT-07|(null)|(null)
C70713|Biospecimen_Type|create|29-OCT-07|(null)|(null)
C70714|Biospecimen_Condition|create|29-OCT-07|(null)|(null)
C70715|Lipemic_Specimen|create|29-OCT-07|(null)|(null)
C70716|Leaking_Specimen|create|29-OCT-07|(null)|(null)
C70717|Frozen_Specimen|create|29-OCT-07|(null)|(null)
C70718|Refrigerated_Specimen|create|29-OCT-07|(null)|(null)
C70719|Specimen_at_Room_Temperature|create|29-OCT-07|(null)|(null)
C70720|Hemolysis_in_Specimen|create|29-OCT-07|(null)|(null)
C70721|Reviewable_Unit|create|29-OCT-07|(null)|(null)
C70722|Investigator_by_Role_in_Study|create|29-OCT-07|(null)|(null)
C70723|Investigator_Status|create|29-OCT-07|(null)|(null)
C70724|Investigator_Registration_Status|create|29-OCT-07|(null)|(null)
C70725|Investigator_Status_in_Study|create|29-OCT-07|(null)|(null)
C70726|Planned_Clinical_Study_Activity|create|29-OCT-07|(null)|(null)
C70727|Assessment_of_Observation_Result|create|29-OCT-07|(null)|(null)
C70728|Information_Status|create|29-OCT-07|(null)|(null)
C70729|Targeted_Anatomic_Site|create|29-OCT-07|(null)|(null)
C70730|Clinical_Study_Population_Subgroup|create|29-OCT-07|(null)|(null)
C70731|Subject_Unique_Identifier|create|29-OCT-07|(null)|(null)
C70732|Study_Subject_Participation_Status|create|29-OCT-07|(null)|(null)
C70733|Subject_Screened_for_Study|create|29-OCT-07|(null)|(null)
C70734|Active_Subject_Participation_Status|create|29-OCT-07|(null)|(null)
C70735|Subject_Completed_Participation_in_Study|create|29-OCT-07|(null)|(null)
C70736|Subject_Participation_Terminated|create|29-OCT-07|(null)|(null)
C70737|Permanent_Intervention_Discontinuation_Subject_Continues_Follow_Up|create|29-OCT-07|(null)|(null)
C70738|Permanent_Intervention_Discontinuation_due_to_Adverse_Event_Subject_Continues_Follow_Up|create|29-OCT-07|(null)|(null)
C70739|Permanent_Intervention_Discontinuation_No_Subject_Follow_Up|create|29-OCT-07|(null)|(null)
C70740|Subject_Lost_to_Follow_Up|create|29-OCT-07|(null)|(null)
C70741|Anti-CD20_Monoclonal_Antibody_R7159|create|29-OCT-07|(null)|(null)
C70742|Treat|create|29-OCT-07|(null)|(null)
C70743|Milestone|create|29-OCT-07|(null)|(null)
C70744|Slope|create|29-OCT-07|(null)|(null)
C70745|Approved_Protocol|create|29-OCT-07|(null)|(null)
C70746|Protocol_Approved_with_Modifications|create|29-OCT-07|(null)|(null)
C70747|Active_Study|create|29-OCT-07|(null)|(null)
C70749|Contour|create|29-OCT-07|(null)|(null)
C70748|Protocol_Disapproved|create|29-OCT-07|(null)|(null)
C70750|Protocol_Deferred|create|29-OCT-07|(null)|(null)
C70751|Study_Closed_to_Accrual|create|29-OCT-07|(null)|(null)
C70752|Study_Closed_to_Accrual_and_Treatment|create|29-OCT-07|(null)|(null)
C70753|Brightness|create|29-OCT-07|(null)|(null)
C70754|Contrast|create|29-OCT-07|(null)|(null)
C70755|Study_on_Hold|create|29-OCT-07|(null)|(null)
C70756|Study_Completed|create|29-OCT-07|(null)|(null)
C70757|Study_Terminated|create|29-OCT-07|(null)|(null)
C70758|Study_Withdrawn|create|29-OCT-07|(null)|(null)
C70759|Performed_Clinical_Study|create|29-OCT-07|(null)|(null)
C70761|Digital_Tomosynthesis_Mammography|create|29-OCT-07|(null)|(null)
C70760|Clinical_Study_Actual_Accrual_Number|create|29-OCT-07|(null)|(null)
C70762|Clinical_Study_Activity_Relationship|create|29-OCT-07|(null)|(null)
C70763|Priority_Number|create|29-OCT-07|(null)|(null)
C70764|Free_Text_Format|create|29-OCT-07|(null)|(null)
C70765|Clinical_Study_Document_Relationship|create|29-OCT-07|(null)|(null)
C70766|Quantitative|create|29-OCT-07|(null)|(null)
C70767|System_of_Measurement|create|29-OCT-07|(null)|(null)
C70768|Laboratory_Test_Result_Status|create|29-OCT-07|(null)|(null)
C70769|Unit_by_System_of_Measurement|create|29-OCT-07|(null)|(null)
C70770|Original_Unit_or_Value_of_Reported_Test_Result|create|29-OCT-07|(null)|(null)
C70772|Knowledge_Field|create|29-OCT-07|(null)|(null)
C25507|Field|split|29-OCT-07|C70772|Knowledge_Field
C25507|Field|split|29-OCT-07|C25507|Field
C25507|Field|split|29-OCT-07|C25507|Field
C70771|Standard_Unit_or_Value_of_Test_Result|create|29-OCT-07|(null)|(null)
C70773|Field_Force|create|29-OCT-07|(null)|(null)
C25507|Field|split|29-OCT-07|C70773|Field_Force
C70774|Unit_Conversion_Factor|create|29-OCT-07|(null)|(null)
C70775|Brownian_Dynamics|create|29-OCT-07|(null)|(null)
C70776|Observation_Outcome_Relationship|create|29-OCT-07|(null)|(null)
C70777|Clinical_Study_Site|create|29-OCT-07|(null)|(null)
C70778|Protocol_Administratively_Withdrawn|create|29-OCT-07|(null)|(null)
C70779|Protocol_Conditionally_Approved|create|29-OCT-07|(null)|(null)
C70780|Laboratory-Generated|create|29-OCT-07|(null)|(null)
C70781|Clinical_Study_Site_by_Role_in_Study|create|29-OCT-07|(null)|(null)
C70783|Clinical_Study_Site_Status|create|29-OCT-07|(null)|(null)
C70785|Clinical_Study_Site_Accrual_Status|create|29-OCT-07|(null)|(null)
C70785|Clinical_Study_Site_Accrual_Status|merge|29-OCT-07|C70785|Clinical_Study_Site_Accrual_Status
C70786|Study_Site_Open_to_Accrual|create|29-OCT-07|(null)|(null)
C70787|Study_Site_Closed_to_Accrual|create|29-OCT-07|(null)|(null)
C70788|Study_Site_Temporarily_Closed_to_Accrual|create|29-OCT-07|(null)|(null)
C70789|Targeted_Accrual_at_Clinical_Study_Site|create|29-OCT-07|(null)|(null)
C70790|Clinical_Study_Lead_Organization|create|29-OCT-07|(null)|(null)
C70791|Participating_Clinical_Study_Organization|create|29-OCT-07|(null)|(null)
C70792|Anti-VEGFR-2_Fully_Human_Monoclonal_Antibody_IMC-1121B|create|29-OCT-07|(null)|(null)
C70793|Clinical_Study_Sponsor|create|29-OCT-07|(null)|(null)
C70794|Primary_Clinical_Study_Sponsor|create|29-OCT-07|(null)|(null)
C70795|Secondary_Clinical_Study_Sponsor|create|29-OCT-07|(null)|(null)
C70796|Eluent|create|29-OCT-07|(null)|(null)
C70797|CD20-targeted_Compound_TRU-015|create|29-OCT-07|(null)|(null)
C70798|Anti-CD45_Monoclonal_Antibody|create|29-OCT-07|(null)|(null)
C70799|Approval_Document|create|29-OCT-07|(null)|(null)
C70800|Institutional_Review_Board_Approval|create|29-OCT-07|(null)|(null)
C70801|Institutional_Review_Board_Approval_Date|create|29-OCT-07|(null)|(null)
C70802|Clinical_Study_Site_Active|create|29-OCT-07|(null)|(null)
C70803|Clinical_Study_Site_Pending_IRB_Approval|create|29-OCT-07|(null)|(null)
C70804|Site_Participation_in_Clinical_Study_Cancelled|create|29-OCT-07|(null)|(null)
C70805|Letter|create|29-OCT-07|(null)|(null)
C70806|Telecommunication_Address|create|29-OCT-07|(null)|(null)
C70808|Telecommunication_Address_Usage_Type|create|29-OCT-07|(null)|(null)
C70809|Communication_Resource_Usage_Type|create|29-OCT-07|(null)|(null)
C70810|Date_of_Death|create|29-OCT-07|(null)|(null)
C70811|Household_Income|create|29-OCT-07|(null)|(null)
C70812|Bone_Metastases_Treatment|create|29-OCT-07|(null)|(null)
C70813|Voltage|create|29-OCT-07|(null)|(null)
C70814|Regulated_Industry|create|29-OCT-07|(null)|(null)
C70815|Buffer|create|29-OCT-07|(null)|(null)
C70816|Regulated_Industry_Unique_Identifier|create|29-OCT-07|(null)|(null)
C70817|Study_Protocol|create|29-OCT-07|(null)|(null)
C70818|Terminology_Concept_Unique_Identifier|create|29-OCT-07|(null)|(null)
C70819|Clinical_Study_by_Targeted_Disease_or_Condition|create|29-OCT-07|(null)|(null)
C70820|Clinical_Study_by_Phase|create|29-OCT-07|(null)|(null)
C70821|Clinical_Study_by_Design|create|29-OCT-07|(null)|(null)
C70824|Clinical_Study_by_Organizational_Parameters|create|29-OCT-07|(null)|(null)
C70825|American_Society_of_Anesthesiologists|create|29-OCT-07|(null)|(null)
C70826|Fit|create|29-OCT-07|(null)|(null)
C70827|Recovery_Generic|create|29-OCT-07|(null)|(null)
C70828|Curve_Mathematical|create|29-OCT-07|(null)|(null)
C70829|Protocol_Information_Office|create|29-OCT-07|(null)|(null)
C70830|Solution|create|29-OCT-07|(null)|(null)
C70831|Amplitude|create|29-OCT-07|(null)|(null)
C70832|Radio_Frequency|create|29-OCT-07|(null)|(null)
C70833|Study_Population|create|29-OCT-07|(null)|(null)
C70834|Description_of_Study_Population|create|29-OCT-07|(null)|(null)
C70835|Study_Subject_Type|create|29-OCT-07|(null)|(null)
C70836|Autologous_LMP1-LMP2-Specific_Cytotoxic_T-Lymphocytes|create|29-OCT-07|(null)|(null)
C70837|Sample_Study_Population|create|29-OCT-07|(null)|(null)
C70838|Image_Feature|create|29-OCT-07|(null)|(null)
C70839|Ion_Trap|create|29-OCT-07|(null)|(null)
C70841|Hexapole|create|29-OCT-07|(null)|(null)
C70840|Blinded_Clinical_Study|create|29-OCT-07|(null)|(null)
C70842|Net|create|29-OCT-07|(null)|(null)
C70843|Chromint_Software|create|29-OCT-07|(null)|(null)
C70844|Lead_Study_Agent|create|29-OCT-07|(null)|(null)
C70845|Protein_Digestion|create|29-OCT-07|(null)|(null)
C70846|Electrode_Grid|create|29-OCT-07|(null)|(null)
C70847|Streak|create|29-OCT-07|(null)|(null)
C70848|Lot_Number|create|29-OCT-07|(null)|(null)
C70849|Cone_Shape|create|29-OCT-07|(null)|(null)
C70850|CD25-Positive_Neoplastic_Cells_Present|create|29-OCT-07|(null)|(null)
C70851|B44-Positive_Neoplastic_Cells_Present|create|29-OCT-07|(null)|(null)
C70852|HLA-A3_A11_Positive_Cells_Present|create|29-OCT-07|(null)|(null)
C70853|Medical_Product_Stability|create|29-OCT-07|(null)|(null)
C70854|Medical_Product_Expiration_Date|create|29-OCT-07|(null)|(null)
C70855|Medical_Product_Shelf_Life|create|29-OCT-07|(null)|(null)
C70856|Observation_Result|create|29-OCT-07|(null)|(null)
C70857|Date_of_Report|create|29-OCT-07|(null)|(null)
C70858|Uncertainty_of_Observation_Result|create|29-OCT-07|(null)|(null)
C70859|Type_of_Regulatory_Submission_Unit|create|29-OCT-07|(null)|(null)
C70860|Original_Regulatory_Submission|create|29-OCT-07|(null)|(null)
C70861|Amendment_Regulatory_Submission|create|29-OCT-07|(null)|(null)
C70862|Supplemental_Regulatory_Submission|create|29-OCT-07|(null)|(null)
C70863|Regulatory_Submission_Date|create|29-OCT-07|(null)|(null)
C70864|Regulatory_Submission_Receipt_Date|create|29-OCT-07|(null)|(null)
C70865|Document_Status|create|29-OCT-07|(null)|(null)
C70866|Submission_Unit_Status|create|29-OCT-07|(null)|(null)
C70867|Application_Document|create|29-OCT-07|(null)|(null)
C70868|Regulatory_Application|create|29-OCT-07|(null)|(null)
C70869|Regulatory_Submission_Unique_Identifier|create|29-OCT-07|(null)|(null)
C70870|Regulatory_Application_Unique_Identifier|create|29-OCT-07|(null)|(null)
C70871|Type_of_Regulatory_Application|create|29-OCT-07|(null)|(null)
C70872|Device_Classification_513_G_CDRH|create|29-OCT-07|(null)|(null)
C70873|New_Device_Application_CDRH|create|29-OCT-07|(null)|(null)
C70874|Premarket_Notification_Submission|create|29-OCT-07|(null)|(null)
C70875|Product_Development_Protocol|create|29-OCT-07|(null)|(null)
C70876|Reclassification_Petition|create|29-OCT-07|(null)|(null)
C70877|Drug_Master_File|create|29-OCT-07|(null)|(null)
C70878|Investigational_Device_Exemption_520_G_CDRH|create|29-OCT-07|(null)|(null)
C70879|Investigational_Device-Exemption_520_L|create|29-OCT-07|(null)|(null)
C70880|Premarket_Approval_Application|create|29-OCT-07|(null)|(null)
C70881|New_Drug_Application_CBER|create|29-OCT-07|(null)|(null)
C70882|New_Drug_Application_CDER|create|29-OCT-07|(null)|(null)
C70883|Investigational_New_Drug_Exemption_CDER|create|29-OCT-07|(null)|(null)
C70884|Investigational_New_Drug_Exemption_CBER|create|29-OCT-07|(null)|(null)
C70885|Regulatory_Submission|create|29-OCT-07|(null)|(null)
C70886|Type_of_Regulatory_Submission|create|29-OCT-07|(null)|(null)
C70887|Regulatory_Assessment|create|29-OCT-07|(null)|(null)
C70888|Daily_Dose|create|29-OCT-07|(null)|(null)
C70889|Agent_Dose_Decreased|create|29-OCT-07|(null)|(null)
C70890|Agent_Dose_Increased|create|29-OCT-07|(null)|(null)
C70891|Agent_Dose_Tapered|create|29-OCT-07|(null)|(null)
C70892|Type_of_Agent_Dose_Change|create|29-OCT-07|(null)|(null)
C70893|Unplanned_Change_of_Dose_Made|create|29-OCT-07|(null)|(null)
C70894|Planned_Change_of_Dose_Made|create|29-OCT-07|(null)|(null)
C70895|Code_System|create|29-OCT-07|(null)|(null)
C70896|Display_Name|create|29-OCT-07|(null)|(null)
C70897|Code_Qualifier|create|29-OCT-07|(null)|(null)
C70898|Code_Translation|create|29-OCT-07|(null)|(null)
C70899|Document|create|29-OCT-07|(null)|(null)
C70900|Performed_Clinical_Study_Activity|create|29-OCT-07|(null)|(null)
C70901|Study_Activity_Cause_or_Rational|create|29-OCT-07|(null)|(null)
C70902|Concomitant_Agent|create|29-OCT-07|(null)|(null)
C70903|Root_Identifier|create|29-OCT-07|(null)|(null)
C70904|Identifier_Extension|create|29-OCT-07|(null)|(null)
C70905|Myringotomy|create|29-OCT-07|(null)|(null)
C70906|Myringotomy_with_Ear_Tube_Placement|create|29-OCT-07|(null)|(null)
C70907|Central_Institutional_Review_Board|create|29-OCT-07|(null)|(null)
C70908|Esophageal_Dilation|create|29-OCT-07|(null)|(null)
C70909|Mechanical_Ventilation|create|29-OCT-07|(null)|(null)
C70910|Nasogastric_Decompression|create|29-OCT-07|(null)|(null)
C70911|Cardioversion|create|29-OCT-07|(null)|(null)
C70912|Positive_Air_Pressure_Device|create|29-OCT-07|(null)|(null)
C70913|Bioavailability|create|29-OCT-07|(null)|(null)
C70914|Biological_Clearance_Rate|create|29-OCT-07|(null)|(null)
C70915|Elimination_Half_Life|create|29-OCT-07|(null)|(null)
C70916|Half_Life|create|29-OCT-07|(null)|(null)
C70917|Distribution_Volume|create|29-OCT-07|(null)|(null)
C70918|Cmax|create|29-OCT-07|(null)|(null)
C70919|Tmax|create|29-OCT-07|(null)|(null)
C70920|Toxicology_Finding|create|29-OCT-07|(null)|(null)
C70921|ADME_Finding|create|29-OCT-07|(null)|(null)
C70922|Clinical_Chemistry_Finding|create|29-OCT-07|(null)|(null)
C70923|Diagnostic_Efficacy|create|29-OCT-07|(null)|(null)
C70924|Therapeutic_Efficacy|create|29-OCT-07|(null)|(null)
C70928|Fasting_Status_at_Specimen_Collection|create|29-OCT-07|(null)|(null)
C70929|Comment_on_Clinical_Study_Activity_Relationship|create|29-OCT-07|(null)|(null)
C70930|Comment_on_Test_Result_Reference_Range|create|29-OCT-07|(null)|(null)
C70931|Comment_on_Observation_Result_Relationship|create|29-OCT-07|(null)|(null)
C70932|Laboratory-Generated_Comment|create|29-OCT-07|(null)|(null)
C70933|High_Test_Reference_Range|create|29-OCT-07|(null)|(null)
C70934|Low_Test_Reference_Range|create|29-OCT-07|(null)|(null)
C70935|Test_Reference_Text_List|create|29-OCT-07|(null)|(null)
C70936|Comment_on_Study_Activity|create|29-OCT-07|(null)|(null)
C70937|Cause_or_Rational_for_Missed_Study_Activity|create|29-OCT-07|(null)|(null)
C70938|Mononeuritis_Multiplex|create|29-OCT-07|(null)|(null)
C70939|Randomization_Indicator|create|29-OCT-07|(null)|(null)
C70940|Frequency-Domain_Photon_Migration|create|29-OCT-07|(null)|(null)
C70941|Cotinine|create|29-OCT-07|(null)|(null)
C70942|deCODE_Map|create|29-OCT-07|(null)|(null)
C70943|Marshfield_Linkage_Map|create|29-OCT-07|(null)|(null)
C70944|SLM1_Linkage_Map|create|29-OCT-07|(null)|(null)
C70945|Biospecimen_Collection|create|29-OCT-07|(null)|(null)
C70946|Postal_Address|create|29-OCT-07|(null)|(null)
C70947|Investigator_Signature|create|29-OCT-07|(null)|(null)
C70948|Polo-like_Kinase_1_Inhibitor_GSK461364|create|29-OCT-07|(null)|(null)
C70949|Investigator_Official_Credentials|create|29-OCT-07|(null)|(null)
C70950|Test_Result_Report|create|29-OCT-07|(null)|(null)
C70951|Description_of_Test_Result|create|29-OCT-07|(null)|(null)
C70952|Numeric_Test_Result|create|29-OCT-07|(null)|(null)
C70953|Hypoxia_Inducible_Factor_1-Alpha_PX-478|create|29-OCT-07|(null)|(null)
C70954|Comment_on_Laboratory_Procedure|create|29-OCT-07|(null)|(null)
C70955|Type_of_Telecommunication_Address|create|29-OCT-07|(null)|(null)
C70956|Comment_on_Observation_Result|create|29-OCT-07|(null)|(null)
C70957|Reason_for_Variance_of_Study_Administrative_Activity|create|29-OCT-07|(null)|(null)
C70958|Subject_Signature_on_Informed_Consent_Form|create|29-OCT-07|(null)|(null)
C70959|Submission_Unit_Relationship|create|29-OCT-07|(null)|(null)
C70960|Description_of_Clinical_Study_Activity|create|29-OCT-07|(null)|(null)
C70961|Dose_Description|create|29-OCT-07|(null)|(null)
C70962|Agent_Administration|create|29-OCT-07|(null)|(null)
C70963|Drug_Vehicle_Volume|create|29-OCT-07|(null)|(null)
C70964|Code_System_Version|create|29-OCT-07|(null)|(null)
C70965|Study_Author|create|29-OCT-07|(null)|(null)
C70966|Indicator_of_Authorization_for_Release_of_Confidential_Health_Information|create|29-OCT-07|(null)|(null)
C70967|Indicator_of_Original_Unit_or_Value_of_Reported_Test_Result|create|29-OCT-07|(null)|(null)
C70968|Renal_Cell_Carcinoma_Peptides_Vaccine_IMA901|create|29-OCT-07|(null)|(null)
C70969|Mycobacterium_w|create|29-OCT-07|(null)|(null)
C70970|Type_of_Clinical_Study_Activity_Relationship|create|29-OCT-07|(null)|(null)
C70971|Vector-peptide_Conjugated_Paclitaxel|create|29-OCT-07|(null)|(null)
C70972|Type_of_Study_Sponsor|create|29-OCT-07|(null)|(null)
C70973|Indicator_of_Displayable_Identifier|create|29-OCT-07|(null)|(null)
C70975|Document_Subtype|create|29-OCT-07|(null)|(null)
C70976|Drug_Vehicle_Unit_of_Volume|create|29-OCT-07|(null)|(null)
C70977|Scheduled_Study_Activity_Cause_or_Rational|create|29-OCT-07|(null)|(null)
C70978|phastCon|create|29-OCT-07|(null)|(null)
C70979|International_HapMap_Project|create|29-OCT-07|(null)|(null)
C15788|Clinical_Trials_Diagnosis|merge|29-OCT-07|C15733|Diagnostic_Trial
C15788|Clinical_Trials_Diagnosis|retire|29-OCT-07|(null)|(null)
C15733|Diagnostic_Trial|merge|29-OCT-07|C15733|Diagnostic_Trial
C15733|Diagnostic_Trial|merge|29-OCT-07|C15733|Diagnostic_Trial
C16148|Exclusion_Criteria|merge|29-OCT-07|C25370|Exclusion
C16148|Exclusion_Criteria|retire|29-OCT-07|(null)|(null)
C39496|Preventive_Clinical_Trial|merge|29-OCT-07|C49657|Prevention_Study
C39496|Preventive_Clinical_Trial|retire|29-OCT-07|(null)|(null)
C49657|Prevention_Study|merge|29-OCT-07|C49657|Prevention_Study
C49652|Trial_Indication_Type|merge|29-OCT-07|C49652|Trial_Indication_Type
C49652|Trial_Indication_Type|merge|29-OCT-07|C49652|Trial_Indication_Type
C16471|Costs|retire|29-OCT-07|(null)|(null)
C68436|Triglyceride|retire|29-OCT-07|(null)|(null)
C69101|Gram_per_100_Grams|retire|29-OCT-07|(null)|(null)